Cancer Nanotechnology (Nov 2022)

Carbon nanoparticles induce DNA repair and PARP inhibitor resistance associated with nanozyme activity in cancer cells

  • Haiyan Fan,
  • Qinglei Sun,
  • Kanat Dukenbayev,
  • Enrico Benassi,
  • Limara Manarbek,
  • Ayan A. Nurkesh,
  • Medina Khamijan,
  • Chenglin Mu,
  • Guoliang Li,
  • Madina Razbekova,
  • Zhenbang Chen,
  • Amr Amin,
  • Yingqiu Xie

DOI
https://doi.org/10.1186/s12645-022-00144-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Background Quantum nanodots especially carbon nanoparticles (CNPs) have been widely studied in biomedicine in imaging, and drug delivery, but anti-cancer mechanisms remain elusive. Methods Here, we investigated a type of cell death induced by food (beet, soybean) derived CNPs in cancer cells and tested whether CNPs induced DNA damage and resistant to anti-cancer agent PARP inhibitor (PARPi) could be overcome by quantum calculations, TEM, AFM, FT-IR, soft agar assay, and cytotoxicity assay. Results At high doses, CNPs derived from beet lead to a pop-like apoptosis (Carbopoptosis) in cancer cells. Quantum mechanical calculations confirmed CNPs binding with phosphate groups as well as DNA bases. At low doses, CNPs develop PARPi drug resistance through interactions between CNPs and PARPi. A synergistic drug effect was achieved with the combination of phosphatase inhibitor (PPi), PARPi, and CNPs. This is corroborated by the fact that sulfur modulated CNPs which exhibit super high phosphatase nanozyme activity abrogated the CNPs induced colony formation in anchorage-independent cancer cell growth. Conclusion Thus, our data suggest the CNPs intrinsic nanozyme activity of phosphatase may crosstalk with drug resistance, which can be reversed upon modulations.

Keywords